Innovative Solutions & Support Doubles Revenue in Q3, Expands Capacity and Financing for Growth

Innovative Solutions & Support, Inc.

EXTON, PAInnovative Solutions & Support, Inc. (Nasdaq: ISSC) posted strong fiscal third quarter 2025 results, driven by contributions from its newly acquired F-16 product line and progress on its manufacturing expansion. The company also secured a new $100 million credit facility to support future growth initiatives.

Revenue for the quarter ended June 30 rose 105% year-over-year to $24.1 million. Net income increased to $2.4 million, or $0.14 per diluted share, compared with $1.6 million, or $0.09 per share, a year earlier. Adjusted EBITDA climbed 43% to $4.4 million.

Gross profit reached $8.6 million, up from $6.3 million in the same period last year, though gross margin narrowed to 35.6%. The company cited elevated costs on the F-16 line as Honeywell accelerated production and built safety stock before fully transitioning manufacturing to IS&S’s Exton facility. Executives expect margins to improve once the transition is complete in fiscal 2026.

Operating expenses rose to $5.1 million from $4.2 million, reflecting added costs from the Honeywell acquisition, including higher staffing, amortization, and one-time expenses. Still, expenses fell to 21% of revenue, down sharply from 36% a year earlier, underscoring improved operating leverage.

READ:  Toppoint Holdings Sees Metals Growth Amid Softer Waste Paper and Import Volumes

Backlog at quarter’s end stood at $72.4 million, excluding additional long-term program orders with major OEMs such as Pilatus, Textron, Boeing, and Lockheed Martin. New orders in the period totaled $16.9 million.

On the balance sheet, IS&S reported $23.3 million in long-term debt and $0.6 million in cash, resulting in $22.7 million in net debt. Net debt fell $3.5 million during the quarter despite heavy capital spending on the Exton facility expansion. Available liquidity stood at $12.3 million as of June 30.

In July, the company closed a new five-year, $100 million syndicated credit agreement led by JPMorgan Chase Bank, replacing its prior $35 million facility. The agreement includes a $30 million revolving loan, a $25 million term loan, a $45 million delayed draw term loan, and an option to request up to $25 million more under an accordion feature. Management said the expanded facility enhances flexibility for both organic investments and acquisitions.

READ:  STRATA Skin Sciences Eyes Growth from Expanded Reimbursement Despite Q2 Revenue Decline

IS&S completed construction of its Exton manufacturing facility in the quarter, with fit-out expected to finish in early fall. The site will support full integration of the F-16 line and provide additional capacity to scale production.

Chief Executive Officer Shahram Askarpour said the company remains on track to deliver more than 30% revenue and EBITDA growth for the full year. “We continue to be excited by the opportunities across our commercial, business, and military markets and remain committed to a disciplined capital allocation strategy,” he said.

For the first nine months of fiscal 2025, IS&S generated $10.3 million in operating cash flow, compared with $5.4 million in the prior-year period. Capital expenditures rose to $5.5 million from $0.5 million, reflecting investment in the Exton facility, while free cash flow held steady at $4.8 million.

The results highlight a period of rapid growth for IS&S, supported by new defense production, facility expansion, and a strengthened financial position to pursue its long-term growth strategy.

READ:  Onfolio Reports Strong Revenue Growth, Narrowed Losses in Second Quarter

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.